BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33225559)

  • 1. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
    Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
    J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimates of the prevalence of undiagnosed HIV among children living with HIV in Eswatini, Lesotho, Malawi, Namibia, Tanzania, Zambia, and Zimbabwe from 2015 to 2017: an analysis of data from the cross-sectional Population-based HIV Impact Assessment surveys.
    Teasdale CA; Zimba R; Abrams EJ; Sachathep K; Ndagije F; Nuwagaba-Biribonwoha H; Musuka G; Mugurungi O; Maile L; Mahy M; Low A
    Lancet HIV; 2022 Feb; 9(2):e91-e101. PubMed ID: 35120641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of HIV population viral load in twelve sub-Saharan African countries.
    Hladik W; Stupp P; McCracken SD; Justman J; Ndongmo C; Shang J; Dokubo EK; Gummerson E; Koui I; Bodika S; Lobognon R; Brou H; Ryan C; Brown K; Nuwagaba-Biribonwoha H; Kingwara L; Young P; Bronson M; Chege D; Malewo O; Mengistu Y; Koen F; Jahn A; Auld A; Jonnalagadda S; Radin E; Hamunime N; Williams DB; Kayirangwa E; Mugisha V; Mdodo R; Delgado S; Kirungi W; Nelson L; West C; Biraro S; Dzekedzeke K; Barradas D; Mugurungi O; Balachandra S; Kilmarx PH; Musuka G; Patel H; Parekh B; Sleeman K; Domaoal RA; Rutherford G; Motsoane T; Bissek AZ; Farahani M; Voetsch AC
    PLoS One; 2023; 18(6):e0275560. PubMed ID: 37363921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress towards the UNAIDS 90-90-90 targets among persons aged 50 and older living with HIV in 13 African countries.
    Farley SM; Wang C; Bray RM; Low AJ; Delgado S; Hoos D; Kakishozi AN; Harris TG; Nyirenda R; Wadonda N; Li M; Amuri M; Juma J; Kancheya N; Pietersen I; Mutenda N; Natanael S; Aoko A; Ngugi EW; Asiimwe F; Lecher S; Ward J; Chikwanda P; Mugurungi O; Moyo B; Nkurunziza P; Aibo D; Kabala A; Biraro S; Ndagije F; Musuka G; Ndongmo C; Shang J; Dokubo EK; Dimite LE; McCullough-Sanden R; Bissek AC; Getaneh Y; Eshetu F; Nkumbula T; Tenthani L; Kayigamba FR; Kirungi W; Musinguzi J; Balachandra S; Kayirangwa E; Ayite A; West CA; Bodika S; Sleeman K; Patel HK; Brown K; Voetsch AC; El-Sadr WM; Justman JJ
    J Int AIDS Soc; 2022 Sep; 25 Suppl 4(Suppl 4):e26005. PubMed ID: 36176030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
    Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
    J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Viral Load, Viremia, and Recent HIV-1 Infections: Findings From Population-Based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and Zambia.
    Farahani M; Radin E; Saito S; Sachathep KK; Hladik W; Voetsch AC; Auld AF; Balachandra S; Tippett Barr BA; Low A; Smart TF; Musuka G; Jonnalagadda S; Hakim AJ; Wadonda-Kabondo NW; Jahn A; Mugurungi O; Williams DB; Barradas DT; Payne D; Parekh B; Patel H; Wiesner L; Hoos D; Justman JE
    J Acquir Immune Defic Syndr; 2021 Aug; 87(Suppl 1):S81-S88. PubMed ID: 33560041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-Based HIV Impact Assessments Survey Methods, Response, and Quality in Zimbabwe, Malawi, and Zambia.
    Sachathep K; Radin E; Hladik W; Hakim A; Saito S; Burnett J; Brown K; Phillip N; Jonnalagadda S; Low A; Williams D; Patel H; Herman-Roloff A; Musuka G; Barr B; Wadondo-Kabonda N; Chipungu G; Duong Y; Delgado S; Kamocha S; Kinchen S; Kalton G; Schwartz L; Bello G; Mugurungi O; Mulenga L; Parekh B; Porter L; Hoos D; Voetsch AC; Justman J
    J Acquir Immune Defic Syndr; 2021 Aug; 87(Suppl 1):S6-S16. PubMed ID: 34166308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.
    Keiser O; Chi BH; Gsponer T; Boulle A; Orrell C; Phiri S; Maxwell N; Maskew M; Prozesky H; Fox MP; Westfall A; Egger M;
    AIDS; 2011 Sep; 25(14):1761-9. PubMed ID: 21681057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community Based Antiretroviral Treatment in Rural Zimbabwe.
    Chimukangara B; Manasa J; Mitchell R; Nyabadza G; Katzenstein D; Masimirembwa C
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1185-1191. PubMed ID: 28899102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic inequalities in the 90-90-90 target, among people living with HIV in 12 sub-Saharan African countries - Implications for achieving the 95-95-95 target - Analysis of population-based surveys.
    Chipanta D; Amo-Agyei S; Giovenco D; Estill J; Keiser O
    EClinicalMedicine; 2022 Nov; 53():101652. PubMed ID: 36159044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
    J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
    Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ
    BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent advanced HIV disease and viral load suppression in a high-burden setting: Findings from the 2015-6 ZIMPHIA survey.
    Balachandra S; Rogers JH; Ruangtragool L; Radin E; Musuka G; Oboho I; Paulin H; Parekh B; Birhanu S; Takarinda KC; Hakim A; Apollo T
    PLoS One; 2020; 15(6):e0230205. PubMed ID: 32584821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.
    Kabuya M; Musekiwa A; Takuva S; Thabane L; Mbuagbaw L
    Pan Afr Med J; 2023; 46():74. PubMed ID: 38282767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Returning HIV-1 viral load results to participant-selected health facilities in national Population-based HIV Impact Assessment (PHIA) household surveys in three sub-Saharan African Countries, 2015 to 2016.
    Saito S; Duong YT; Metz M; Lee K; Patel H; Sleeman K; Manjengwa J; Ogollah FM; Kasongo W; Mitchell R; Mugurungi O; Chimbwandira F; Moyo C; Maliwa V; Mtengo H; Nkumbula T; Ndongmo CB; Vere NS; Chipungu G; Parekh BS; Justman J; Voetsch AC
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    Szubert AJ; Prendergast AJ; Spyer MJ; Musiime V; Musoke P; Bwakura-Dangarembizi M; Nahirya-Ntege P; Thomason MJ; Ndashimye E; Nkanya I; Senfuma O; Mudenge B; Klein N; Gibb DM; Walker AS;
    PLoS Med; 2017 Nov; 14(11):e1002432. PubMed ID: 29136032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam.
    Tanuma J; Matsumoto S; Haneuse S; Cuong DD; Vu TV; Thuy PTT; Dung NT; Dung NTH; Trung NV; Kinh NV; Oka S
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29211347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
    Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
    Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for HIV Among Patients at Tuberculosis Clinics - Results from Population-Based HIV Impact Assessment Surveys, Malawi, Zambia, and Zimbabwe, 2015-2016.
    Kothegal N; Wang A; Jonnalagadda S; MacNeil A; Radin E; Brown K; Mugurungi O; Choto R; Balachandra S; Rogers JH; Musuka G; Kalua T; Odo M; Auld A; Gunde L; Kim E; Payne D; Lungu P; Mulenga L; Hassani AS; Nkumbula T; Patel H; Parekh B; Voetsch AC
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(10):342-345. PubMed ID: 33705366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.